Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

290
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
290
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

735
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
735

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Symmetrical Low-Voltage Negative Barrier Height Breast Cancer-Associated VOCs Sensing Different-Sized Gold Nanoflower-Functionalized ZnO Thin Films Prepared by a Low Cost Chemical Method.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

RETRACTED: Tomassoni et al. Brain Activity of Thioctic Acid Enantiomers: In Vitro and In Vivo Studies in an Animal Model of Cerebrovascular Injury. <i>Int. J. Mol. Sci.</i> 2013, <i>14</i>, 4580-4595.

International journal of molecular sciences·2026
Same author

Machine Learning Approaches to Early Detection of Parkinson's Disease Using Speech Analysis Technique.

Neurology international·2026
Same author

Telemedicine-Assisted Work-Related Injuries Among Seafarers on Italian-Flagged Ships: A 13-Year Retrospective Study.

Healthcare (Basel, Switzerland)·2025
Same author

Machine Learning-Driven Prediction of Vitamin D Deficiency Severity with Hybrid Optimization.

Bioengineering (Basel, Switzerland)·2025
Same author

Machine Learning Driven by Magnetic Resonance Imaging for the Classification of Alzheimer Disease Progression: Systematic Review and Meta-Analysis.

JMIR aging·2024

Related Experiment Video

Updated: Oct 12, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

403

Improved Alzheimer's Disease Detection by MRI Using Multimodal Machine Learning Algorithms.

Gopi Battineni1, Mohmmad Amran Hossain1, Nalini Chintalapudi1

  • 1Telemedicine and Telepharmacy Centre, School of Medicinal and Health Products Sciences, University of Camerino, 62032 Camerino, Italy.

Diagnostics (Basel, Switzerland)
|November 27, 2021
PubMed
Summary
This summary is machine-generated.

This study uses machine learning and MRI scans to accurately diagnose Alzheimer's disease (AD) in adults. The gradient boosting algorithm achieved 97.58% accuracy, improving upon traditional diagnostic methods.

Keywords:
AUROCAlzheimer’s diseaseDementiamachine learningperformanceprediction

More Related Videos

Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K

Related Experiment Videos

Last Updated: Oct 12, 2025

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

403
Author Spotlight: Advancing Alzheimer's Research &#8211; Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.3K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

8.0K

Area of Science:

  • Neurology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Alzheimer's disease (AD) is the most common form of adult-onset dementia.
  • Traditional AD diagnosis relies on clinical criteria with limited accuracy (85%) and requires post-mortem confirmation.
  • Advancements in Magnetic Resonance Imaging (MRI) and machine learning (ML) offer potential for earlier and more accurate AD detection.

Purpose of the Study:

  • To develop and evaluate a machine learning framework for classifying Alzheimer's disease (AD) versus non-AD subjects.
  • To leverage longitudinal brain MRI features for improved diagnostic accuracy.
  • To compare the performance of six supervised learning classifiers for AD detection.

Main Methods:

  • A supervised learning framework was implemented using longitudinal brain MRI data.
  • Six distinct supervised classification algorithms were employed for AD subject categorization.
  • Patient demographic information and pre-existing conditions were considered to enhance classifier performance.

Main Results:

  • The gradient boosting algorithm demonstrated superior performance among the evaluated models.
  • The proposed framework achieved a high accuracy of 97.58% in classifying AD subjects.
  • The study highlights the potential of ML applied to MRI for precise AD diagnosis.

Conclusions:

  • Machine learning models, particularly gradient boosting, show significant promise for accurate and early Alzheimer's disease diagnosis using MRI.
  • Integrating demographic and clinical data can further enhance the predictive power of ML classifiers for AD.
  • This approach offers a non-invasive method to aid in the definitive diagnosis of AD, potentially improving patient management.